Frank Pasqualone
2017
In 2017, Frank Pasqualone earned a total compensation of $906.3K as Senior Vice President and Global Head, Acute Care Business at Theravance Biopharma, a 59% decrease compared to previous year.
Compensation breakdown
| Bonus | $45,574 |
|---|---|
| Non-Equity Incentive Plan | $68,360 |
| Salary | $505,145 |
| Stock Awards | $281,160 |
| Other | $6,020 |
| Total | $906,259 |
Pasqualone received $505.1K in salary, accounting for 56% of the total pay in 2017.
Pasqualone also received $45.6K in bonus, $68.4K in non-equity incentive plan, $281.2K in stock awards and $6K in other compensation.
Rankings
In 2017, Frank Pasqualone's compensation ranked 9,451st out of 14,666 executives tracked by ExecPay. In other words, Pasqualone earned more than 35.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,451 out of 14,666 | 36th |
Division Manufacturing | 3,634 out of 5,772 | 37th |
Major group Chemicals And Allied Products | 1,254 out of 2,075 | 40th |
Industry group Drugs | 1,008 out of 1,731 | 42nd |
Industry Pharmaceutical Preparations | 791 out of 1,333 | 41st |
Source: SEC filing on March 21, 2018.
Pasqualone's colleagues
We found four more compensation records of executives who worked with Frank Pasqualone at Theravance Biopharma in 2017.